An improved method for the assay of TiO2 purity and its determination in drugs using flame atomic absorption spectrometry.

Authors:

Abstract
A quantitative method for determining TiO2 was developed. The proposed method is based on analysis by flame atomic absorption spectrometry (FAAS) and presents advantages over the current pharmacopeial monographs for TiO2 assay by dispensing the use of mercury for sample pretreatment. Solid drugs (tablets and capsules) and TiO2 were decomposed by a mixture of sulfuric acid/ammonium sulfate, diluted, and analyzed by FAAS. The method was validated according to the USP Validation of Compendia Procedure and the USP Atomic Absorption Spectroscopy monograph. All parameters were in accordance with the compendium criteria. Analysis of a TiO2 powder standard sample, which showed purity (99.5%) within the established limits, confirms the adequacy of the proposed method. Six samples were analyzed following the proposed method and consisted of three TiO2 samples from different suppliers and three different drugs, Cozaar (Merck) and Zocor (Merck) tablets, and Peprazol (Libbs) capsules, which were expected to contain TiO2 as an ingredient. The purity of the assayed TiO2 samples ranged from 79.2% to 90.5%, and the amount of TiO2 in the drugs from 2.8 to 3.8 mg/g.